Learner eligibility – final-year Fees Free
Source: Tertiary Education Commission Last updated 21 May 2025 Last updated 21 May 2025 Print Share This page sets out the learner eligibility criteria for the final-year Fees Free policy....
MIL-OSI: Data > Intelligence > News
Source: Tertiary Education Commission Last updated 21 May 2025 Last updated 21 May 2025 Print Share This page sets out the learner eligibility criteria for the final-year Fees Free policy....
Source: Tertiary Education Commission Last updated 17 February 2025 Last updated 17 February 2025 Print Share This page provides information about transition to DXP Ngā Kete and changes to data...
Source: Tertiary Education Commission Last updated 12 November 2024 Last updated 12 November 2024 Print Share This page contains information about the data requirements for Other Fund Actuals data submission...
Source: PHARMAC Pharmac is consulting on a proposal to fund more medicines for melanoma, a type of skin cancer, from 1 June 2025. The medicines are: pembrolizumab (branded as Keytruda)...
Source: PHARMAC Pharmac’s Board has begun the search for a new Chief Executive, advertising in New Zealand and overseas. Board Chair Paula Bennett says the Board is looking for a...
Source: PHARMAC Funding nivolumab in combination with ipilimumab for eligible people with kidney cancer We expect about 110 people with metastatic kidney cancer will benefit in the first year of...
Source: PHARMAC Pharmac has decided to fund a new progestogen-only oral contraceptive pill called desogestrel (branded as Cerazette). Melissa Copland, Pharmac’s Clinical Lead–Medicines Management, says desogestrel will be funded for...
Source: PHARMAC Pharmac Board Chair Paula Bennett is welcoming an independent report calling for stronger, more respectful relationships with consumers to ensure their voices are listened to and included in...
Source: PHARMAC Information on what the Pharmacology and Therapeutics Advisory Committee (PTAC) will be considering at its meeting in May 2025. Applications Foslevodopa / foscarbidopa for advanced Parkinson disease The...
Source: PHARMAC Pharmac is seeking feedback on a proposal to make it easier for people with asthma to access a type of inhaler. “We’re proposing two changes, which would make...
Source: PHARMAC More New Zealanders will have access to medicines for blood cancers, bowel diseases, eczema and arthritis, following Pharmac’s decision to widen access to four medicines for six health...
Source: PHARMAC Pharmac is consulting on a proposal that would make it easier for thousands of New Zealanders to access contraceptives. Pharmac’s Clinical Lead – Medicines Management, Melissa Copland, says...
Source: PHARMAC Pharmac is seeking feedback on a proposal to fund two brands of oestradiol patches for New Zealanders to use – Estradot, and Estradiol TDP Mylan. If approved, Pharmac...
Source: Tertiary Education Commission Last updated 21 May 2025 Last updated 21 May 2025 Print Share The Minister for Vocational Education has announced the government’s decision to introduce an industry-led...
Source: Tertiary Education Commission Last updated 21 May 2025 Last updated 21 May 2025 Print Share In December 2023, the Government announced its intention to disestablish Te Pūkenga | New...
Source: Tertiary Education Commission Last updated 21 May 2025 Last updated 21 May 2025 Print Share This page provides information about the data required for reporting Work-based delivery (Actuals) on...
Source: Tertiary Education Commission On this page: Claiming Fees Free entitlement From 2026, after completing their first eligible provider-based qualification or work-based programme, learners will log in to myIR to...
Source: PHARMAC Pharmac is sharing the agenda for the upcoming Rare Disorders Advisory Committee meeting to be held on Tuesday 10 June 2025. Note the meeting date is now one...
Source: PHARMAC An independent review has found that Pharmac needs to make significant organisational changes over the next five years to meet public and stakeholders’ expectations. Pharmac’s Board commissioned organisational...
Source: PHARMAC Life was admin heavy “Life was just admin heavy. I was doing injections every day and testing my blood sugar at every meal, so I was ecstatic when...
Source: PHARMAC Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its half-day meeting in May 2025. Correspondence and matters arising discussion papers Potential oncology agent...
Source: New Zealand Film Commission The New Zealand Film Commission is offering up to 15 scholarships for industry practitioners who live in regional areas of Aotearoa, identify as deaf, disabled...
Source: New Zealand Film Commission The New Zealand Film Commission (NZFC) congratulates the outstanding achievements of the Māoriland Charitable Trust and Craig Gainsborough of Greenlit, recognised at the prestigious 2025...
Source: PHARMAC Pharmac is proposing a change to the Pharmaceutical Schedule rules, which if agreed, would give New Zealanders with cancer greater continuity of care. Pharmac is consulting on a...
Source: PHARMAC Pharmac is proposing to fully fund two liquid nutrition replacements for adults with Crohn’s disease who use them as their only source of nutrition. Crohn’s is a type...
Source: PHARMAC Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from 1 May 2025. Pharmac’s Director Pharmaceuticals, Geraldine MacGibbon, expects about 13,000* people...
Source: PHARMAC 9 May 2025 Media release Medicines COVID-19 Pharmac has today opened consultation on a proposal to simplify the criteria for people accessing COVID-19 antiviral medicines, along with the...